Every SEC Form 3/4/5 on record for this filer (CIK 1298709) — 2 issuers, 253 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | President and CEO · Director | 2017-09-19 → 2026-06-05 | 38 | −$125M |
| XON | INTREXON CORP | Chief Operating Officer · lapsed | 2015-12-04 → 2016-02-01 | 2 | −$745,308 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KRYS | 2026-06-04 | Sell | 11,461 | $307.68 | $4M | 1,461,523 |
| KRYS | 2026-06-04 | Sell | 589 | $306.33 | $180,428 | 1,472,984 |
| KRYS | 2026-06-04 | Sell | 544 | $304.81 | $165,817 | 1,473,573 |
| KRYS | 2026-06-04 | Sell | 4,830 | $308.47 | $1M | 1,456,693 |
| KRYS | 2026-06-04 | Sell | 2,784 | $309.49 | $861,620 | 1,453,909 |
| KRYS | 2026-06-04 | Sell | 2,652 | $310.43 | $823,260 | 1,451,257 |
| KRYS | 2026-06-04 | Sell | 964 | $311.36 | $300,151 | 1,450,293 |
| KRYS | 2026-06-04 | Sell | 40 | $312.23 | $12,489 | 1,450,253 |
| KRYS | 2026-06-04 | Sell | 176 | $303.17 | $53,358 | 1,474,117 |
| KRYS | 2026-06-04 | Sell | 640 | $302.24 | $193,434 | 1,474,293 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.